For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to ...

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

GSK has gained approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab), as an add-on maintenance treatment for the adult population with chronic ...

Pegtarazimod holds promise for effectively treating acute exacerbations of COPD, a major unmet need in COPD treatment.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The ...

To explore opportunities for improving care based on the experiences and perspectives of different types of COPD patients based on the Information-Motivation-Behavioral skills (IMB) model with poor ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that obstructs airflow and makes breathing difficult. It encompasses several respiratory conditions, including chronic ...

Add Yahoo as a preferred source to see more of our stories on Google. Dec. 10—(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD) ...

Add Yahoo as a preferred source to see more of our stories on Google. A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do before.

Chronic obstructive pulmonary disease, or COPD, is a complex and progressive disease, and many patients continue to experience exacerbations, also known as flare-ups. For the past few decades, the ...